CMS has made mistakes in its proposed inpatient payments for fiscal year 2007, and the device industry will suffer because of it, stakeholders say
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
Remepy is exploring two potential regulatory pathways to support this strategy. The first is a combination product pathway that would formally integrate software and drug into a single therapeutic entity. The second is the FDA’s Prescription Drug Use-Related Software (PDURS) pathway.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
Medtronic is teaming up with IRCAD North America to build high-tech training and education experiences for surgeons and medical professionals in cardiovascular, neuroscience, and minimally invasive surgical specialties. The move could also further position Medtronic to seize on the growing robotics
